MIT’s Associate Professor Bryan Bryson is uncovering how Myobacterium tuberculosis interacts with our immune systems, in a focus that could reshape TB vaccine strategies. By translating these biological insights into engineering solutions, Bryson hopes to help eliminate a disease that remains a global challenge.